These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18676410)

  • 101. Immunomodulatory functions of the diffuse neuroendocrine system: implications for bronchopulmonary dysplasia.
    Sunday ME; Shan L; Subramaniam M
    Endocr Pathol; 2004; 15(2):91-106. PubMed ID: 15299196
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Similarities and dissimilarities of branching and septation during lung development.
    Roth-Kleiner M; Post M
    Pediatr Pulmonol; 2005 Aug; 40(2):113-34. PubMed ID: 15965895
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Possible interactions of genetic and immuno-neuro-endocrine regulatory mechanisms in pathogenesis of congenital anomalies.
    Sljivic S; Kamenov B; Maglajlic S; Djordjevic V; Stojkovic-Eferica I; Stojanovic M; Stefanovic M; Mihailovic D; Mrkaic L; Tasic G
    Med Hypotheses; 2006; 67(1):57-64. PubMed ID: 16574341
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Metabolomics of bronchopulmonary dysplasia.
    Piersigilli F; Bhandari V
    Clin Chim Acta; 2020 Jan; 500():109-114. PubMed ID: 31689411
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Cellular and molecular responses to lung injury in relation to induction of tissue repair and fibrosis.
    Finkelstein JN; Horowitz S; Sinkin RA; Ryan RM
    Clin Perinatol; 1992 Sep; 19(3):603-20. PubMed ID: 1526074
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Markers and mediators of inflammation in neonatal lung disease.
    Ozdemir A; Brown MA; Morgan WJ
    Pediatr Pulmonol; 1997 Apr; 23(4):292-306. PubMed ID: 9141115
    [No Abstract]   [Full Text] [Related]  

  • 107. Association of immune cell recruitment and BPD development.
    Heydarian M; Schulz C; Stoeger T; Hilgendorff A
    Mol Cell Pediatr; 2022 Aug; 9(1):16. PubMed ID: 35917002
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Leveraging Microbial Symbiosis to Modulate Bronchopulmonary Dysplasia.
    Peterson LS; Scheible K
    Am J Respir Cell Mol Biol; 2023 Mar; 68(3):235-236. PubMed ID: 36346615
    [No Abstract]   [Full Text] [Related]  

  • 109. Glycogen in inflammatory mononuclear cells of premature and mature newborn infants.
    Prindull G; Prindull B
    J Reticuloendothel Soc; 1970 May; 7(5):594-6. PubMed ID: 5436504
    [No Abstract]   [Full Text] [Related]  

  • 110. Significance of oxidants and inflammatory mediators in blood of patients undergoing cardiac surgery.
    Elahi MM; Yii M; Matata BM
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):455-67. PubMed ID: 18503942
    [No Abstract]   [Full Text] [Related]  

  • 111. Induced hypothermia as a new approach to bronchopulmonary dysplasia.
    Kumral A; Yesilirmak D; Tuzun F; Duman N; Ozkan H
    Med Hypotheses; 2008 Oct; 71(4):617-8. PubMed ID: 18614292
    [No Abstract]   [Full Text] [Related]  

  • 112. New markers in pneumonia.
    Cheng CW; Chien MH; Su SC; Yang SF
    Clin Chim Acta; 2013 Apr; 419():19-25. PubMed ID: 23384502
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The crucial roles of inflammatory mediators in inflammation: A review.
    Abdulkhaleq LA; Assi MA; Abdullah R; Zamri-Saad M; Taufiq-Yap YH; Hezmee MNM
    Vet World; 2018 May; 11(5):627-635. PubMed ID: 29915501
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Bronchopulmonary dysplasia.
    Thébaud B; Goss KN; Laughon M; Whitsett JA; Abman SH; Steinhorn RH; Aschner JL; Davis PG; McGrath-Morrow SA; Soll RF; Jobe AH
    Nat Rev Dis Primers; 2019 Nov; 5(1):78. PubMed ID: 31727986
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies.
    Principi N; Di Pietro GM; Esposito S
    J Transl Med; 2018 Feb; 16(1):36. PubMed ID: 29463286
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.
    Kalikkot Thekkeveedu R; Guaman MC; Shivanna B
    Respir Med; 2017 Nov; 132():170-177. PubMed ID: 29229093
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Mechanisms of Lung Injury and Bronchopulmonary Dysplasia.
    Jobe AH
    Am J Perinatol; 2016 Sep; 33(11):1076-8. PubMed ID: 27603539
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Epidemiology of bronchopulmonary dysplasia.
    Jensen EA; Schmidt B
    Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):145-57. PubMed ID: 24639412
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.
    Papagianis PC; Pillow JJ; Moss TJ
    Paediatr Respir Rev; 2019 Apr; 30():34-41. PubMed ID: 30201135
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Ciclesonide exhibits lung-protective effects in neonatal rats exposed to intra-amniotic enterotoxin.
    Mielgo V; Gastiasoro E; Catozzi C; Ricci F; Gomez-Solaetxe MA; Murgia X; Rey-Santano C
    Front Pediatr; 2024; 12():1428520. PubMed ID: 39403347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.